New round saw participation of new investors Progress Tech Transfer, HTH, Eureka! Venture and LIFTT on top of continued support of existing shareholders led by Panakès Partners.
Certaldo (Florence), Italy, June 4th, 2021 – Endostart, an ISO13485 certified endoscopy platform company targeting incomplete colonoscopies, today announced it has closed a €8.2M in new financing from new and existing investors. The Series B investment round has seen participation from Progress Tech Transfer, HTH, EUREKA! Venture SGR, LIFTT and continued support from existing shareholders Panakès Partners, Estor, A11 Venture and experienced business angels. Endostart will use the funds to industrialize and commercially launch Endorail®, a CE-marked endoscopic magnetic balloon guidewire aimed at facilitating fast colonoscopy completion.Download Press release